Bit of Background These new classes of antiobesity medications (ie, the GLP-1 agonists and dual agonists), referred to in this article as weight management medications, arent really new.1-4 The basic science and pharmaceutical research and development to bring these to market began more than two decades ago when two scientists, Matthias Tschop, MD, and Richard DiMarchi, PhD, hypothesized that the actions of various gut hormones may offer safe and unprecedented weight loss
The medication also acts on areas of the brain involved in appetite regulation, further reducing food intake
A prendre avec une alimentation saine et quilibre
What are ways to deal with the side effects of GLP-1
In a seminal study, researchers added Epithalon to human fetal fibroblasts that lacked detectable telomerase activity
Team Novello Clinics It offers a personalized assessment to accurately determine the cost and ensure you get the best results for the right price